-
1
-
-
0025892132
-
Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias
-
Jorm AF. Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias. Eur Arch Psychiatry Clin Neurosci 1991;240:218-22.
-
(1991)
Eur Arch Psychiatry Clin Neurosci
, vol.240
, pp. 218-222
-
-
Jorm, A.F.1
-
2
-
-
0042023711
-
Alzheimer disease in the US population: Prevalence estimates using the 2000 census
-
Hebert LE, Scherr PA, Bienias JL, et al. Alzheimer disease in the US population: Prevalence estimates using the 2000 census. Arch Neurol 2003;60:1119-22.
-
(2003)
Arch Neurol
, vol.60
, pp. 1119-1122
-
-
Hebert, L.E.1
Scherr, P.A.2
Bienias, J.L.3
-
7
-
-
21544467552
-
Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials
-
Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, et al. Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ 2005;331:321-7.
-
(2005)
BMJ
, vol.331
, pp. 321-327
-
-
Kaduszkiewicz, H.1
Zimmermann, T.2
Beck-Bornholdt, H.P.3
-
8
-
-
3042567016
-
Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial
-
Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): Randomised double-blind trial. Lancet 2004;363:2105-15.
-
(2004)
Lancet
, vol.363
, pp. 2105-2115
-
-
Courtney, C.1
Farrell, D.2
Gray, R.3
-
9
-
-
0141954291
-
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
-
Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Review 2003;9:275-308.
-
(2003)
CNS Drug Review
, vol.9
, pp. 275-308
-
-
Rogawski, M.A.1
Wenk, G.L.2
-
11
-
-
0345872128
-
Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial
-
Tariot PN, Farlow MR, Grossberg GT et al. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil. A randomized controlled trial. JAMA 2004;291:317-24.
-
(2004)
JAMA
, vol.291
, pp. 317-324
-
-
Tariot, P.N.1
Farlow, M.R.2
Grossberg, G.T.3
-
12
-
-
0030967165
-
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study
-
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336:1216-22.
-
(1997)
N Engl J Med
, vol.336
, pp. 1216-1222
-
-
Sano, M.1
Ernesto, C.2
Thomas, R.G.3
-
14
-
-
2942750157
-
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study
-
Espeland M, Rapp S, Shumaker S, et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004;291:2959-68.
-
(2004)
JAMA
, vol.291
, pp. 2959-2968
-
-
Espeland, M.1
Rapp, S.2
Shumaker, S.3
-
15
-
-
0030759072
-
A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia
-
North American EGb Study Group
-
Le Bars PL, Katz MM, Berman N, et al. A placebo-controlled, double-blind, randomized trial of an extract of ginkgo biloba for dementia. North American EGb Study Group. JAMA 1997;278:1327-32.
-
(1997)
JAMA
, vol.278
, pp. 1327-1332
-
-
Le Bars, P.L.1
Katz, M.M.2
Berman, N.3
-
17
-
-
0032441698
-
Complementary and alternative medicines for Alzheimer's disease
-
Ott BR, Owens NJ. Complementary and alternative medicines for Alzheimer's disease. J Geriatr Psychiatry Neurol 1998;11:163-73.
-
(1998)
J Geriatr Psychiatry Neurol
, vol.11
, pp. 163-173
-
-
Ott, B.R.1
Owens, N.J.2
-
18
-
-
2942550480
-
Behavioral problems in dementia. Strategies for pharmacologic and nonpharmacologic management
-
47-52
-
Smith A. Behavioral problems in dementia. Strategies for pharmacologic and nonpharmacologic management. Postgrad Med 2004;115:47-52, 55-6.
-
(2004)
Postgrad Med
, vol.115
, pp. 55-56
-
-
Smith, A.1
-
19
-
-
0028839754
-
Psychiatric and physical morbidity effects of dementia caregiving: Prevalence, correlates, and causes
-
Schultz R, O'Brien AT, Bookwala J, et al. Psychiatric and physical morbidity effects of dementia caregiving: Prevalence, correlates, and causes. Gerontologist 1995;35:771-91.
-
(1995)
Gerontologist
, vol.35
, pp. 771-791
-
-
Schultz, R.1
O'Brien, A.T.2
Bookwala, J.3
-
20
-
-
2442564527
-
Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease
-
Mittelman MS, Roth DL, Coon DW, et al. Sustained benefit of supportive intervention for depressive symptoms in caregivers of patients with Alzheimer's disease. Am J Psychiatry 2004;161:850-6.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 850-856
-
-
Mittelman, M.S.1
Roth, D.L.2
Coon, D.W.3
-
21
-
-
0024378857
-
Effect of a training programme to reduce stress in carers of patients with dementia
-
Brodaty H, Gresham M. Effect of a training programme to reduce stress in carers of patients with dementia. BMJ 1989;299:1375-9.
-
(1989)
BMJ
, vol.299
, pp. 1375-1379
-
-
Brodaty, H.1
Gresham, M.2
-
22
-
-
0038070244
-
Meta-analysis of psychosocial interventions for caregivers of people with dementia
-
Brodaty H, Green A, Koschera A Meta-analysis of psychosocial interventions for caregivers of people with dementia. J Am Geriatr Soc 2003;51:657-64.
-
(2003)
J Am Geriatr Soc
, vol.51
, pp. 657-664
-
-
Brodaty, H.1
Green, A.2
Koschera, A.3
-
23
-
-
0035826771
-
Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Doody RS, Stevens JC, Beck C, et al. Practice parameter: Management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-66.
-
(2001)
Neurology
, vol.56
, pp. 1154-1166
-
-
Doody, R.S.1
Stevens, J.C.2
Beck, C.3
-
24
-
-
66749125384
-
Online support and education for dementia caregivers: Overview, utilization, and initial program evaluation
-
Glueckauf RL, Ketterson TU, Loomis JS, et al. Online support and education for dementia caregivers: Overview, utilization, and initial program evaluation. Telemed J E Health, 2004;10:223-32.
-
(2004)
Telemed J E Health
, vol.10
, pp. 223-232
-
-
Glueckauf, R.L.1
Ketterson, T.U.2
Loomis, J.S.3
-
25
-
-
0030801772
-
Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society
-
Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363-71.
-
(1997)
JAMA
, vol.278
, pp. 1363-1371
-
-
Small, G.W.1
Rabins, P.V.2
Barry, P.P.3
-
27
-
-
0037096921
-
Guidelines for managing Alzheimer's disease: Part II. Treatment
-
Cummings JL, Frank JC, Cherry D, et al. Guidelines for managing Alzheimer's disease: Part II. Treatment. Am Fam Physician 2002;65:2525-34.
-
(2002)
Am Fam Physician
, vol.65
, pp. 2525-2534
-
-
Cummings, J.L.1
Frank, J.C.2
Cherry, D.3
-
30
-
-
0036169018
-
Effect of light treatment on sleep and circadian rhythms in demented nursing home patients
-
Ancoli-Israel S, Martin JL, Kripke DF, et al. Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc 2002;50:282-9.
-
(2002)
J Am Geriatr Soc
, vol.50
, pp. 282-289
-
-
Ancoli-Israel, S.1
Martin, J.L.2
Kripke, D.F.3
-
31
-
-
0037220291
-
Identifying driving impairment in Alzheimer disease: A comparison of self and observer reports versus driving evaluation
-
Wild K, Cotrell V. Identifying driving impairment in Alzheimer disease: A comparison of self and observer reports versus driving evaluation. Alzheimer Dis Assoc Disord 2003;17:27-34.
-
(2003)
Alzheimer Dis Assoc Disord
, vol.17
, pp. 27-34
-
-
Wild, K.1
Cotrell, V.2
-
32
-
-
0034720818
-
Practice parameter: Risk of driving and Alzheimer's disease (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology
-
Dubinsky RM, Stein AC, Lyons K. Practice parameter: Risk of driving and Alzheimer's disease (an evidence-based review): Report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2000;54:2205-11.
-
(2000)
Neurology
, vol.54
, pp. 2205-2211
-
-
Dubinsky, R.M.1
Stein, A.C.2
Lyons, K.3
-
33
-
-
0028889485
-
Statement on use of apolipoprotein E testing for Alzheimer disease
-
American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease
-
American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. Statement on use of apolipoprotein E testing for Alzheimer disease. JAMA 1995;274:1627-9.
-
(1995)
JAMA
, vol.274
, pp. 1627-1629
-
-
-
35
-
-
0003467013
-
Guidelines for Alzheimer's disease management: Final report
-
California Workgroup on Guidelines for Alzheimer's Disease Management. Department of Health Services
-
California Workgroup on Guidelines for Alzheimer's Disease Management. Guidelines for Alzheimer's disease management: Final report. Department of Health Services, 1999.
-
(1999)
-
-
-
36
-
-
0040746449
-
Providing care for the caregiver
-
Young MG. Providing care for the caregiver. Patient Care 2001;35:68.
-
(2001)
Patient Care
, vol.35
, pp. 68
-
-
Young, M.G.1
|